Sep 10, 2026 08:30AM
Aug 31, 2026 06:05AM
Aug 29, 2026 11:00AM
Aug 26, 2026 09:20AM
Aug 13, 2026 05:12PM
Aug 13, 2026 05:12PM
Aug 13, 2026 08:01AM Atrium Therapeutics receives $15M milestone from Bristol Myers Squibb
Aug 13, 2026 08:00AM
Jul 13, 2026 06:59AM
Jul 13, 2026 06:59AM
Jun 24, 2026 08:30AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:59AM
Jun 1, 2026 06:56AM Bristol Myers Squibb gains EU approval for Opdivo combination in lymphoma
Jun 1, 2026 06:55AM
May 8, 2026 07:00AM
May 8, 2026 06:59AM
Apr 21, 2026 07:00AM
Mar 30, 2026 04:21AM
Mar 29, 2026 11:45AM
Mar 29, 2026 11:45AM Bristol Myers Squibb Presents Positive Results from Phase 3 SCOUT-HCM Trial Demonstrating Efficacy and Safety of Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyo
Mar 23, 2026 09:00AM
Mar 20, 2026 04:42PM
Mar 20, 2026 04:42PM
Mar 6, 2026 09:59PM
Mar 6, 2026 09:59PM
Feb 26, 2026 06:59AM
Feb 26, 2026 06:59AM SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple
Feb 17, 2026 05:31PM
Feb 17, 2026 07:00AM
Feb 17, 2026 06:59AM
Feb 13, 2026 03:04PM
Feb 4, 2026 06:59AM
Feb 4, 2026 06:59AM
Jan 22, 2026 07:00AM Bristol Myers Squibb partners with Microsoft on lung cancer AI detection
Jan 22, 2026 07:00AM
Jan 20, 2026 06:59AM
Jan 20, 2026 06:59AM
Jan 12, 2026 06:59AM
Jan 12, 2026 06:59AM
Dec 19, 2025 12:39PM
Dec 11, 2025 06:59AM FDA grants priority review to Bristol Myers Squibb Opdivo combo for lymphoma
Dec 11, 2025 06:59AM
Dec 8, 2025 04:31PM
Dec 8, 2025 04:30PM
Dec 5, 2025 06:00AM
Dec 4, 2025 08:15PM
Dec 3, 2025 01:45PM
Dec 3, 2025 06:59AM Bristol Myers Squibb continues alzheimer's psychosis study after site review
Dec 3, 2025 06:59AM

331,378 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All